Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of azilsartan in adults with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilsartan (azilsartan)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 2 | Status: COMPLETED